BREAKTHROUGH T1D: Form 990, tax year 2019
View the entire original 990 at ProPublica ↗
- Organization
- BREAKTHROUGH T1D (EIN 23-1907729)
- Tax period
- 2019-07-01 to 2020-06-30
- Filed
- 2021-04-08
- IRS object ID
- 202140989349301304
- Schema version
- 2019v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2021-04-08T14:41:14-05:00 | ReturnTs |
| Tax Period End | 2020-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KPMG LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 345 PARK AVE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10154 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2019-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 231907729 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF INTERNATIONAL | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % EMMA PANGILINAN-ROSALES | InCareOfNm |
| Business Name Control | JDRF | BusinessNameControlTxt |
| Phone | 2126892860 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 200 VESEY STREET 28TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10281 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | JOANNE MARTZ | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 2124797550 | PhoneNum |
| Signature | 2021-04-05 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | EVAN W SEEKAMP | PreparerPersonNm |
| PTIN | P01907071 | PTIN |
| Phone | 2127589700 | PhoneNum |
| Preparation | 2021-04-05 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2019 | TaxYr |
| Build TS | 2022-09-23 18:48:47Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | AARON KOWALSKI | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 200 VESEY STREET 28TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10281 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $274,899,230 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.jdrf.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1970 | FormationYr |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Activity Or Mission | Improving lives today and tomorrow by accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications. SEE SCHEDULE O, ATTACH. 1. | ActivityOrMissionDesc |
| Voting Members Governing Body | 13 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 13 | VotingMembersIndependentCnt |
| Total Employee | 868 | TotalEmployeeCnt |
| Total Volunteers | 235000 | TotalVolunteersCnt |
| Total Gross UBI | $49,734 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $29,579 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $215,659,011 | PYContributionsGrantsAmt |
| CY Contributions Grants | $194,074,339 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $19,973,309 | PYInvestmentIncomeAmt |
| CY Investment Income | $16,238,938 | CYInvestmentIncomeAmt |
| PY Other Revenue | $3,697,145 | PYOtherRevenueAmt |
| CY Other Revenue | $2,289,173 | CYOtherRevenueAmt |
| PY Total Revenue | $239,329,465 | PYTotalRevenueAmt |
| CY Total Revenue | $212,602,450 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $89,137,491 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $68,847,301 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $80,309,185 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $77,701,531 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $339,984 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $27,446 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $34,666,848 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $42,783,392 | PYOtherExpensesAmt |
| CY Other Expenses | $46,029,373 | CYOtherExpensesAmt |
| PY Total Expenses | $212,570,052 | PYTotalExpensesAmt |
| CY Total Expenses | $192,605,651 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $26,759,413 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $19,996,799 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $244,434,766 | TotalAssetsBOYAmt |
| Total Assets EOY | $268,023,077 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $128,633,286 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $134,322,376 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $115,801,480 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $133,700,701 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | AT JDRF, WE WORK TIRELESSLY TO ACCELERATE BREAKTHROUGHS TO CURE, PREVENT AND TREAT TYPE 1 DIABETES (T1D). WE CONTINUALLY EXPAND OUR SCIENTIFIC KNOWLEDGE, OUR CONNECTIONS AND COLLABORATIONS, OUR PARTNERS AND GLOBAL PRESENCE TO UNLOCK THE SCIENCE THAT WILL STOP T1D. WHILE WE FIGHT FOR A CURE, WE STRIVE JUST AS HARD TO DEVELOP THERAPIES TO HELP PEOPLE RIGHT NOW. JDRF AND OUR SCIENTISTS ARE LEADING T1D RESEARCH AROUND THE WORLD. WE ADDRESS KEY GAPS TO MOVE RESEARCH FASTER AND FARTHER ACROSS THE DEVELOPMENT PIPELINE AND TO TRANSLATE BREAKTHROUGHS INTO NEW THERAPIES FOR PEOPLE WITH T1D. THIS ENABLES US TO ADVANCE SCIENCE WITH THE MOST POTENTIAL AND TO DRIVE RESEARCH THAT ATTRACTS MORE RESOURCES AND SCIENTIFIC EXPERTISE TO THE FIELD. WE INVEST IN THE EARLY STAGES, ALLOWING RESEARCHERS TO PURSUE INNOVATIVE IDEAS AND APPROACHES THAT WILL LEAD TO BREAKTHROUGH TREATMENTS. JDRF ALSO WORKS TO DRIVE NEW THERAPIES AND TECHNOLOGIES TO MARKET SO THEY GET INTO THE HANDS OF PEOPLE WITH T1D MORE QUICKLY. | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $68,847,301 | ExpenseAmt |
| Grant | $68,847,301 | GrantAmt |
| Desc | RESEARCH FUNDING - FOR THE FY20 PERIOD ENDING JUNE 30, 2020, JDRF DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $69 MILLION IN RESEARCH GRANT EXPENSE, NET WAS RECOGNIZED ACCORDING TO GAAP AND EXCLUDING $50 MILLION OF PROGRAMMATIC RESEARCH INVESTMENTS WHICH ARE RECORDED TO THE ORGANIZATION'S BALANCE SHEET. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO DIRECT RESEARCH FUNDING, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $16,997,889 | ExpenseAmt |
| Desc | RESEARCH SUPPORT - JDRF MAINTAINS AN IN-HOUSE TEAM OF SKILLED SCIENTIFIC, MEDICAL, POLICY AND GOVERNMENT RELATIONS PROFESSIONALS WHO PLAY A CRITICAL ROLE IN LEADING AND SUPPORTING THE EVALUATION OF RESEARCH FUNDING OPPORTUNITIES BY JDRF AND INFLUENCING RESEARCH DIRECTION AND THE DISBURSEMENT OF RESEARCH FUNDS FROM OTHERS. THESE PROFESSIONALS ALSO WORK WITH REGULATORY AND POLICY OFFICIALS TO ENSURE THAT RESEARCH CAN PROCEED WITHOUT DELAY AND RESULTS ARE UNDERSTOOD BY HEALTHCARE DECISION MAKERS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO RESEARCH SUPPORT, SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $50,681,132 | ExpenseAmt |
| Desc | PUBLIC EDUCATION AND OUTREACH - JDRF EDUCATES THE COMMUNITY AND PROVIDES OUTREACH SERVICES TO NEWLY DIAGNOSED CHILDREN AND ADULTS, THEIR FAMILIES AND OTHERS ABOUT T1D AND ITS COMPLICATIONS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO PUBLIC EDUCATION AND OUTREACH, SEE SCHEDULE O. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $136,526,322 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (true) | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (true) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | false | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | Yes (true) | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | Yes (true) | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | false | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | false | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | Yes (true) | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | false | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| IRP Document | 1014 | IRPDocumentCnt |
| IRP Document W2 G | 6 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 868 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | IS | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Form1098 C Filed | Yes (true) | Form1098CFiledInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | false | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | false | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 13 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 13 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | Yes (true) | LocalChaptersInd |
| Policies Reference Chapters | Yes (true) | PoliciesReferenceChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | Yes (true) | InvestmentInJointVentureInd |
| Written Policy Or Procedure | Yes (true) | WrittenPolicyOrProcedureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ID | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TX | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WY | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | EMMA PANGILINAN-ROSALES | PersonNm |
| Phone | 2124797550 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 200 VESEY STREET 28TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10281 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (27 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd |
|---|---|---|---|---|---|---|---|---|---|---|
| DEREK RAPP THRU 0419 | ||||||||||
| PRESIDENT AND CEO | 0.0 | 0.0 | Yes (X) | $870,371 | $0 | $11,538 | ||||
| AARON KOWALSKI | ||||||||||
| PRESIDENT AND CEO | 50.0 | 0.0 | $654,519 | $0 | $46,292 | Yes (X) | ||||
| HELEN ELIAS | ||||||||||
| MANAGING DIR. JDRF T1D FUND | 50.0 | 0.0 | $450,498 | $0 | $25,833 | Yes (X) | ||||
| SANDRA HIJIKATA THRU 0420 | ||||||||||
| CHIEF DEV OFFICER & ASST. SECY | 50.0 | 0.0 | $450,550 | $0 | $24,944 | Yes (X) | ||||
| JOANNE MARTZ | ||||||||||
| CFO/TREASURER | 50.0 | 0.0 | $416,133 | $0 | $34,916 | Yes (X) | ||||
| ALISA NORRIS | ||||||||||
| CHIEF MARKETING OFFICER | 50.0 | 0.0 | $375,000 | $0 | $46,988 | Yes (X) | ||||
| CYNTHIA RICE | ||||||||||
| CHIEF MISSION OFFICER | 50.0 | 0.0 | $370,834 | $0 | $31,152 | Yes (X) | ||||
| SRINIVAS MISHRA | ||||||||||
| CHIEF DATA AND TECHNOLOGY | 50.0 | 0.0 | $363,067 | $0 | $34,061 | Yes (X) | ||||
| SUSAN YUN THRU 0520 | ||||||||||
| CHIEF PEOPLE OFFICER/ASST. SEC | 50.0 | 0.0 | $373,433 | $0 | $14,973 | Yes (X) | ||||
| JILL CLARK | ||||||||||
| SVP, VOLUNTEER ENGAGEMENT | 50.0 | 0.0 | $359,900 | $0 | $19,588 | Yes (X) | ||||
| SANJOY DUTTA | ||||||||||
| VP, RESEARCH | 50.0 | 0.0 | $286,171 | $0 | $16,155 | Yes (X) | ||||
| SYDNEY YOVIC | ||||||||||
| CHIEF OF STAFF/ASST. TREASURER | 50.0 | 0.0 | $185,085 | $0 | $32,984 | Yes (X) | ||||
| JAMES MCDONALD | ||||||||||
| BOARD LIAISON/SECRETARY | 50.0 | 0.0 | $109,130 | $0 | $6,065 | Yes (X) | ||||
| ELLEN LEAKE | ||||||||||
| CHAIR OF THE BOARD | 20.0 | 0.0 | $0 | $0 | $0 | Yes (X) | Yes (X) | |||
| MARGERY PERRY | ||||||||||
| CHAIR, RESEARCH | 5.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| LISA WALLACK | ||||||||||
| BOARD MEMBER | 5.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| PAUL HEATH | ||||||||||
| CHAIR, ADVOCACY & IMPACT | 3.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| JEFF PLUMER | ||||||||||
| BOARD VICE-CHAIR | 10.0 | 0.0 | $0 | $0 | $0 | Yes (X) | Yes (X) | |||
| GRANT BEARD | ||||||||||
| CHAIR, AUDIT & RISK COMMITTEE | 5.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| STEVEN DAVIS | ||||||||||
| CHAIR, NOMINATING & GOVERNANCE | 3.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| JOE LACHER | ||||||||||
| CHAIR, TALENT & COMPENSATION | 5.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| JENNIFER SCHNEIDER MD | ||||||||||
| BOARD MEMBER | 3.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| MATT VAREY | ||||||||||
| BOARD MEMBER | 3.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| CHRISTOPHER TURNER | ||||||||||
| CHAIR, FINANCE & INVESTMENTS | 5.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| MICHAEL ALTER | ||||||||||
| CHAIR, FUNDING COMMITTEE | 3.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| CLAUDIA GRAHAM | ||||||||||
| BOARD MEMBER | 3.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| TROY LINDLOFF BEGAN 0220 | ||||||||||
| CDO/ASST. TREASURER | 50.0 | 0.0 | $0 | $0 | $0 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $5,264,691 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $345,489 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 201 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (true) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | CountryContractorAddress/ForeignAddress/CountryCd |
|---|---|---|---|---|---|---|---|---|---|
| BLUE STATE DIGITAL | |||||||||
| 41 FLATBUSH AVE | BROOKLYN | NY | 11217 | WEB DEVELOPMENT | $1,903,583 | ||||
| KAVYOS CONSULTING INC | |||||||||
| 485 US-1 | ISELIN | NJ | 08830 | IT CONSULTANTS | $1,663,170 | ||||
| JOHN GALLIN SON INC | |||||||||
| 102 MADISON AVE 9TH FL | NEW YORK | NY | 10016 | GENERAL CONTRACTOR | $2,541,820 | ||||
| INNOVATION CLOUD LLC | |||||||||
| IT CONSULTANTS | $1,336,808 | RUE DE LINDUSTRIE 15 L-8069 | BERTRANGE | 0 | LU | ||||
| MED-IQ LLC | |||||||||
| 5523 RESEARCH PARK DR STE 210 | BALTIMORE | MD | 21228 | PROF. CONSULTANTS | $482,886 | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 34 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $3,973,328 | FederatedCampaignsAmt |
| Fundraising | $109,565,253 | FundraisingAmt |
| All Other Contributions | $80,535,758 | AllOtherContributionsAmt |
| Noncash Contributions | $12,160,404 | NoncashContributionsAmt |
| Total Contributions | $194,074,339 | TotalContributionsAmt |
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $2,968,472 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $49,734 | UnrelatedBusinessRevenueAmt |
| Exclusion | $2,918,738 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $57,078,984 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $43,808,518 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $13,270,466 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $13,270,466 | TotalRevenueColumnAmt |
| Exclusion | $13,270,466 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $18,254,759 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $109,565,252 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $18,254,759 | FundraisingDirectExpensesAmt |
| Gaming Gross Income | $850,956 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $233,503 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $617,453 | TotalRevenueColumnAmt |
| Exclusion | $617,453 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | MISC REVENUE | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $1,671,720 | TotalRevenueColumnAmt |
| Exclusion | $1,671,720 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $1,671,720 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $212,602,450 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $49,734 | UnrelatedBusinessRevenueAmt |
| Exclusion | $18,478,377 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $47,676,980 | TotalAmt |
| Program Services | $47,676,980 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,170,321 | TotalAmt |
| Program Services | $21,170,321 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,271,140 | TotalAmt |
| Program Services | $1,362,684 | ProgramServicesAmt |
| Management And General | $317,960 | ManagementAndGeneralAmt |
| Fundraising | $590,496 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $59,971,320 | TotalAmt |
| Program Services | $33,919,245 | ProgramServicesAmt |
| Management And General | $10,585,372 | ManagementAndGeneralAmt |
| Fundraising | $15,466,703 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $10,155,549 | TotalAmt |
| Program Services | $5,805,316 | ProgramServicesAmt |
| Management And General | $1,610,683 | ManagementAndGeneralAmt |
| Fundraising | $2,739,550 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,303,522 | TotalAmt |
| Program Services | $2,848,001 | ProgramServicesAmt |
| Management And General | $987,183 | ManagementAndGeneralAmt |
| Fundraising | $1,468,338 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,448,293 | TotalAmt |
| Program Services | $1,334,249 | ProgramServicesAmt |
| Management And General | $154,938 | ManagementAndGeneralAmt |
| Fundraising | $959,106 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $520,511 | TotalAmt |
| Program Services | $153,799 | ProgramServicesAmt |
| Management And General | $260,220 | ManagementAndGeneralAmt |
| Fundraising | $106,492 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $254,540 | TotalAmt |
| Management And General | $254,540 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $853,826 | TotalAmt |
| Program Services | $853,826 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $27,446 | TotalAmt |
| Fundraising | $27,446 | FundraisingAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $319,620 | TotalAmt |
| Management And General | $319,620 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,924,455 | TotalAmt |
| Program Services | $1,743,975 | ProgramServicesAmt |
| Management And General | $1,020,688 | ManagementAndGeneralAmt |
| Fundraising | $1,159,792 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,718,131 | TotalAmt |
| Program Services | $2,545,090 | ProgramServicesAmt |
| Management And General | $313,831 | ManagementAndGeneralAmt |
| Fundraising | $1,859,210 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,676,281 | TotalAmt |
| Program Services | $894,241 | ProgramServicesAmt |
| Management And General | $365,257 | ManagementAndGeneralAmt |
| Fundraising | $416,783 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,524,385 | TotalAmt |
| Program Services | $2,595,691 | ProgramServicesAmt |
| Management And General | $1,261,834 | ManagementAndGeneralAmt |
| Fundraising | $2,666,860 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,966,787 | TotalAmt |
| Program Services | $4,696,657 | ProgramServicesAmt |
| Management And General | $1,682,529 | ManagementAndGeneralAmt |
| Fundraising | $2,587,601 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,882,582 | TotalAmt |
| Program Services | $1,745,565 | ProgramServicesAmt |
| Management And General | $301,825 | ManagementAndGeneralAmt |
| Fundraising | $835,192 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,175,240 | TotalAmt |
| Program Services | $465,852 | ProgramServicesAmt |
| Management And General | $201,827 | ManagementAndGeneralAmt |
| Fundraising | $507,561 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $45,282 | TotalAmt |
| Program Services | $45,282 | ProgramServicesAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,192,966 | TotalAmt |
| Program Services | $1,423,148 | ProgramServicesAmt |
| Management And General | $887,956 | ManagementAndGeneralAmt |
| Fundraising | $1,881,862 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $612,366 | TotalAmt |
| Program Services | $261,320 | ProgramServicesAmt |
| Management And General | $193,328 | ManagementAndGeneralAmt |
| Fundraising | $157,718 | FundraisingAmt |
Other Expenses OtherExpensesGrp (3 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| OUTREACH EXPENSES | $5,189,866 | $3,994,526 | $414,210 | $781,130 |
| DUES & FEES | $831,976 | $453,321 | $159,919 | $218,736 |
| OTHER MISC EXPENSES | $892,266 | $537,233 | $118,761 | $236,272 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $192,605,651 | TotalAmt |
| Program Services | $136,526,322 | ProgramServicesAmt |
| Management And General | $21,412,481 | ManagementAndGeneralAmt |
| Fundraising | $34,666,848 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | Yes (X) | JointCostsInd |
Total Joint Costs TotalJointCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,005,061 | TotalAmt |
| Program Services | $501,444 | ProgramServicesAmt |
| Fundraising | $1,503,616 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part X | Yes (X) | InfoInScheduleOPartXInd |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $19,125,818 | BOYAmt |
| EOY | $18,028,084 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $36,566,833 | BOYAmt |
| EOY | $29,732,492 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $30,267,097 | BOYAmt |
| EOY | $36,176,968 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $20,525,959 | BOYAmt |
| EOY | $7,962,575 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,720,000 | BOYAmt |
| EOY | $3,870,000 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,103,129 | BOYAmt |
| EOY | $7,022,535 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $15,578,062 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $4,173,382 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $5,895,032 | BOYAmt |
| EOY | $11,404,680 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $93,573,878 | BOYAmt |
| EOY | $102,925,827 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,213,073 | BOYAmt |
| EOY | $857,686 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $21,443,947 | BOYAmt |
| EOY | $50,042,230 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $244,434,766 | BOYAmt |
| EOY | $268,023,077 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $16,774,462 | BOYAmt |
| EOY | $24,845,175 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $100,065,608 | BOYAmt |
| EOY | $99,239,193 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,232,753 | BOYAmt |
| EOY | $7,730,761 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,560,463 | BOYAmt |
| EOY | $2,507,247 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $128,633,286 | BOYAmt |
| EOY | $134,322,376 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $76,838,325 | BOYAmt |
| EOY | $85,538,657 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,963,155 | BOYAmt |
| EOY | $48,162,044 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $115,801,480 | BOYAmt |
| EOY | $133,700,701 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $244,434,766 | BOYAmt |
| EOY | $268,023,077 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $19,996,799 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | -$2,097,578 | NetUnrlzdGainsLossesInvstAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $196,804,267 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $199,896,852 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $219,968,105 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $215,659,011 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $194,074,339 | CurrentTaxYearAmt |
| Total | $1,026,402,574 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $196,804,267 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $199,896,852 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $219,968,105 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $215,659,011 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $194,074,339 | CurrentTaxYearAmt |
| Total | $1,026,402,574 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $0 | SubstantialContributorsTotAmt |
| Public Support Total170 | $1,026,402,574 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $465,379 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $548,825 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,309,523 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,439,225 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $2,918,738 | CurrentTaxYearAmt |
| Total | $7,681,690 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $112,437 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $33,150 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $138,747 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $186,965 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $29,579 | CurrentTaxYearAmt |
| Total | $500,878 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $94,769 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $283,014 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,793,044 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $2,313,482 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,671,720 | CurrentTaxYearAmt |
| Total | $6,156,029 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $1,040,741,171 | TotalSupportAmt |
| Public Support CY170 | 0.98622 | PublicSupportCY170Pct |
| Public Support PY170 | 0.98740 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Form4720 Filed | false | Form4720FiledInd |
| Volunteers | Yes (true) | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | Yes (true) | MediaAdvertisementsInd |
| Media Advertisements | $16,450 | MediaAdvertisementsAmt |
| Mailings Members | false | MailingsMembersInd |
| Mailings Members | $0 | MailingsMembersAmt |
| Publications Or Broadcast | Yes (true) | PublicationsOrBroadcastInd |
| Publications Or Broadcast | $17,625 | PublicationsOrBroadcastAmt |
| Grants Other Organizations | Yes (true) | GrantsOtherOrganizationsInd |
| Grants Other Organizations | $2,343 | GrantsOtherOrganizationsAmt |
| Direct Contact Legislators | Yes (true) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $526,529 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | Yes (true) | RalliesDemonstrationsInd |
| Rallies Demonstrations | $462,701 | RalliesDemonstrationsAmt |
| Other Activities | Yes (true) | OtherActivitiesInd |
| Other Activities | $1,147 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $1,026,795 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | JDRF LOBBYING ACTIVITIES | FormAndLineReferenceDesc |
| Explanation | FORM 990- SCH-C- GENERAL STATEMENT OF ACTIVITIES JDRF is the leading global organization funding type 1 diabetes (T1D) research, focused on curing T1D and improving lives. JDRF's advocacy includes lobbying activity to ensure Congress continues to invest in critically important medical research and puts in place policies to advance development and access to therapies to cure T1D and help people stay as healthy as possible until that day. JDRF has been instrumental in securing the renewal of the Special Diabetes Program, which provides $150MM annually for T1D research at the National Institutes of Health. JDRF staff and volunteers communicate with government officials through email, phone calls, and meetings, to educate them on issues and encourage the advancement of legislation. | ExplanationTxt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,887,833 | BeginningYearBalanceAmt |
| Contributions | -$140,727 | ContributionsAmt |
| Investment Earnings Or Losses | $33,086 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $71,023 | OtherExpendituresAmt |
| End Year Balance | $7,709,169 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,567,601 | BeginningYearBalanceAmt |
| Contributions | $221,441 | ContributionsAmt |
| Investment Earnings Or Losses | $102,034 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $3,243 | OtherExpendituresAmt |
| End Year Balance | $7,887,833 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,341,367 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $268,304 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $42,070 | OtherExpendituresAmt |
| End Year Balance | $7,567,601 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,176,427 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $367,446 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $202,506 | OtherExpendituresAmt |
| End Year Balance | $7,341,367 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,141,514 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $37,913 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $3,000 | OtherExpendituresAmt |
| End Year Balance | $7,176,427 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.00000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 1.00000 | PrmnntEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
| Land | LandGrp | |
| Buildings | BuildingsGrp |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $5,269,771 | OtherCostOrOtherBasisAmt |
| Depreciation | $4,783,263 | DepreciationAmt |
| Book Value | $486,508 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $15,578,062 | OtherCostOrOtherBasisAmt |
| Depreciation | $4,659,890 | DepreciationAmt |
| Book Value | $10,918,172 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Land Buildings | OtherLandBuildingsGrp | |
| Total Book Value Land Buildings | $11,404,680 | TotalBookValueLandBuildingsAmt |
Invst Program Related Org InvstProgramRelatedOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | T1D FUND PROGRAM RELATED INVES | Desc |
| Book Value | $50,042,230 | BookValueAmt |
| Method Valuation | F | MethodValuationCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Program Rltd | $50,042,230 | TotalBookValueProgramRltdAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | SPLIT INTEREST CHRT RMDR TRUST | Desc |
| Amt | $2,507,247 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $2,507,247 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $210,185,251 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | -$2,097,579 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | -$2,097,579 | RevenueNotReportedAmt |
| Revenue Subtotal | $212,282,830 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $319,620 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $319,620 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $212,602,450 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $192,286,031 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Subtotal | $192,286,031 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $319,620 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $319,620 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $192,605,651 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| ORGANIZATION'S ENDOWMENT FUNDS | FORM 990, PART X, LINE 28 & 29 & SCH D, PART V THE ORGANIZATION UTILIZES EARNINGS ON ENDOWMENT FUNDS IN THE MANNER SPECIFIED BY THE DONOR AND/OR FOR SUPPORTING THE ORGANIZATIONS GENERAL EXEMPT PURPOSE. |
| UNCERTAIN TAX POSITIONS | 990 SCH-D, PART X, LINE 2 JDRF IS A NOT FOR PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501 (C) (3) OF THE INTERNAL REVENUE CODE AND IS ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA. THE EFFECT OF INCOME INCOME TAX POSITIONS IS RECOGNIZED ONLY IF THE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO JDRF'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. UNRELATED BUSINESS INCOME TAX LIABILITY WAS INSIGNIFICANT FOR THE YEARS ENDING JUNE 30, 2020 AND 2019. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | OfficesOfficesCnt | EmployeeEmployeeCnt |
|---|---|---|---|---|---|
| East Asia and the Pacific | Grantmaking | RESEARCH GRANTS | $5,200,123 | ||
| Europe (Including Iceland and Greenland) | Grantmaking | RESEARCH GRANTS | $12,596,152 | ||
| Middle East and North Africa | Grantmaking | RESEARCH GRANTS | $761,742 | ||
| North America | Grantmaking | RESEARCH GRANTS | $2,032,241 | ||
| South Asia | Grantmaking | RESEARCH GRANTS | $618,750 | ||
| Central America and the Caribbean | Investments | INVESTMENTS | $28,320 | ||
| Europe (Including Iceland and Greenland) | Program Services | RESEARCH SUPPORT | $537,616 | 2 | 2 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 2 | SubtotalOfficesCnt |
| Subtotal Employees | 2 | SubtotalEmployeesCnt |
| Total Office | 2 | TotalOfficeCnt |
| Total Employee | 2 | TotalEmployeeCnt |
| Subtotal Spent | $21,774,944 | SubtotalSpentAmt |
| Total Spent | $21,774,944 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (64 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Description Of Non Cash AsstDescriptionOfNonCashAsstTxt | Valuation Method UsedValuationMethodUsedDesc |
|---|---|---|---|---|---|
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $195,000 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | PREVENTION | $37,185 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $120,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $705,195 | CHECK/WIRE | N/A | N/A |
| Middle East and North Africa | $62,853 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNOTHERAPIES | $807,719 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | $574,445 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | IMMUNOTHERAPIES | $1,475,385 | CHECK/WIRE | N/A | N/A |
| North America | IMMUNE THERAPIES | $60,816 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNOTHERAPIES | $63,529 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | PREVENTION | $160,000 | CHECK/WIRE | N/A | N/A |
| North America | $859,430 | CHECK/WIRE | N/A | N/A | |
| North America | BETA CELL REPLACEMENT | $544,578 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $110,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $444,396 | CHECK/WIRE | N/A | N/A |
| North America | BETA CELL REGENERATION | $148,924 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $261,295 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL REGENERATION | $146,601 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | BETA CELL REPLACEMENT | $109,994 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | TRANSPORTFOLIO | $175,000 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | PREVENTION | $625,728 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $1,192,020 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | COMPLICATIONS | $522,660 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL REGENERATION | $26,949 | CHECK/WIRE | N/A | N/A |
| North America | $92,280 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | PREVENTION | $64,649 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $361,020 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THEPAPIES | $318,106 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $489,216 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | PREVENTION | $30,221 | CHECK/WIRE | N/A | N/A |
| North America | IMMUNE THERAPIES | $248,430 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $119,821 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | BETA CELL | $62,500 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $1,392,697 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | IMMUNE THERAPIES | $618,750 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | ARTIFICIAL PANCREAS | $859,399 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL REPLACEMENT | $521,988 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | METABOLIC CONTROL | $154,085 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | IMMUNE THERAPIES | $484,125 | CHECK/WIRE | N/A | N/A |
| North America | IMMUNE THERAPIES | $80,550 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $413,423 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $62,640 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | MISSION | $600,000 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | PREVENTION | $69,060 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $243,750 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | PREVENTION | $485,728 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $300,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | TRANSPORTFOLIO | $287,643 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | METABOLIC CONTROL | $199,927 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL REGENERATION | $95,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | ARTIFICIAL PANCREAS | $418,664 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | ARTIFICIAL PANCREAS | $100,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNOTHERAPIES | $615,241 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL | $250,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $249,808 | CHECK/WIRE | N/A | N/A |
| Middle East and North Africa | ARTIFICIAL PANCREAS | $481,475 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $315,621 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | BETA CELL REPLACEMENT | $109,963 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | TRANSPORTFOLIO | $54,013 | CHECK/WIRE | N/A | N/A |
| Middle East and North Africa | TRANSPORTFOLIO | $333,060 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL REPLACEMENT | $102,881 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | METABOLIC CONTROL, PREVENTION | $330,777 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL REGENERATION | $62,640 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | TRANSPORTFOLIO | $125,000 | CHECK/WIRE | N/A | N/A |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 55 | Total501c3OrgCnt |
| Total Other Org | 9 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | Yes (true) | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | Yes (true) | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | GRANT MONITORING PROCEDURES | FormAndLineReferenceDesc |
| Explanation | SCH-F PART I LINE 2 RESEARCH GRANTS ARE AWARDED BY JDRF INTERNATIONAL WITH THE SUPPORT OF JDRFI'S RESEARCH COMMITTEE COMPRISED OF "JDRF INTERNATIONAL BOARD MEMBERS AND OTHER VOLUNTEERS" FOLLOWING THE RECOMMENDATIONS OF AN IN-HOUSE TEAM OF PROFESSIONAL SCIENTIFIC STAFF AND WITH INPUT FROM EXTERNAL SCIENTIFIC REVIEWERS. THE REVIEW PROCESS INCLUDES THE FOLLOWING CRITERIA: (1) THE SCIENTIFIC MERIT OF THE PROPOSED RESEARCH OUTLINED IN A GRANT APPLICATION AND (2) THE RELATIONSHIP OF THE PROPOSED RESEARCH TO JDRF'S GOAL TO IMPROVE LIVES TODAY AND TOMORROW BY ACCELERATING LIFE-CHANGING BREAKTHROUGHS TO CURE, PREVENT AND TREAT T1D AND ITS COMPLICATIONS. THE SCIENTIFIC RESEARCH TEAM AND GRANT ADMINISTRATION STAFF MAINTAIN CLOSE CONTACT WITH GRANTEES, PROVIDING ADVICE AND EVALUATION, REVIEWING PROGRESS REPORTS, REVIEWING RESEARCH EXPENDITURES VERSUS AGREED BUDGETS, AND HELPING DISSEMINATE RESEARCH RESULTS. | ExplanationTxt |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | CARS CHARITABLE ADULT RIDES AND SE | PersonNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4669 MURPHY CANYON RD STE 200 | AddressLine1Txt |
| City | SAN DIEGO | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 92123 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activity | CAR DONATION | ActivityTxt |
| Fundraiser Control Of Funds | Yes (true) | FundraiserControlOfFundsInd |
| Gross Receipts | $137,540 | GrossReceiptsAmt |
| Retained By Contractor | $27,446 | RetainedByContractorAmt |
| Net To Organization | $110,094 | NetToOrganizationAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $137,540 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $27,446 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $110,094 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AZ | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DE | LicensedStatesCd |
| Licensed States | DC | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | ID | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | IN | LicensedStatesCd |
| Licensed States | IA | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | NE | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | SD | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | TX | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
| Licensed States | WY | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | ILLINOIS GALA | Event1Nm |
| Gross Receipts Event1 | $7,154,385 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $6,250,224 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $904,161 | GrossRevenueEvent1Amt |
| Rent Facility Costs Event1 | $37,960 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $325,914 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $410,752 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $129,535 | OtherDirectExpensesEvent1Amt |
| Event2 | NYC/LI BALL | Event2Nm |
| Gross Receipts Event2 | $2,307,514 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $1,945,685 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $361,829 | GrossRevenueEvent2Amt |
| Non Cash Prizes Event2 | $1,189 | NonCashPrizesEvent2Amt |
| Food And Beverage Event2 | $170,959 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $131,750 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $57,931 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 0 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $118,358,113 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $101,369,344 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $16,988,769 | GrossRevenueOtherEventsAmt |
| Non Cash Prizes Other Events | $223,503 | NonCashPrizesOtherEventsAmt |
| Rent Fclty Costs Other Events | $1,153,201 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $1,824,097 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $2,757,216 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $11,030,752 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $127,820,012 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $109,565,253 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $18,254,759 | GrossRevenueTotalEventsAmt |
| Non Cash Prizes Total Events | $224,692 | NonCashPrizesTotalEventsAmt |
| Rent Fclty Costs Total Events | $1,191,161 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $2,320,970 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $3,299,718 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $11,218,218 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $18,254,759 | DirectExpenseSummaryEventsAmt |
Gaming Information GamingInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Revenue Other Gaming | $850,956 | GrossRevenueOtherGamingAmt |
| Non Cash Prizes Other Gaming | $18,545 | NonCashPrizesOtherGamingAmt |
| Rent Fclty Costs Other Gaming | $214,958 | RentFcltyCostsOtherGamingAmt |
| Volunteer Labor Other Gaming | false | VolunteerLaborOtherGamingInd |
| Gross Revenue Total Gaming | $850,956 | GrossRevenueTotalGamingAmt |
| Non Cash Prizes Total Gaming | $18,545 | NonCashPrizesTotalGamingAmt |
| Rent Fclty Costs Total Gaming | $214,958 | RentFcltyCostsTotalGamingAmt |
| Direct Expense Summary Gaming | $233,503 | DirectExpenseSummaryGamingAmt |
| Net Gaming Income Summary | $617,453 | NetGamingIncomeSummaryAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| States Where Gaming Conducted | AL | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | AK | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | AZ | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | AR | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | CA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | CO | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | CT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | DE | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | DC | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | FL | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | GA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | HI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | ID | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | IL | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | IN | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | IA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | KS | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | KY | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | LA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | ME | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MD | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MN | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MS | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MO | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NE | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NV | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NH | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NJ | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NM | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NY | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NC | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | ND | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | OH | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | OK | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | OR | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | PA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | RI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | SC | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | SD | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | TN | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | TX | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | UT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | VT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | VA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WV | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WY | StatesWhereGamingConductedCd |
| Licensed | Yes (true) | LicensedInd |
| License Suspended Etc | false | LicenseSuspendedEtcInd |
| Gaming With Nonmembers | false | GamingWithNonmembersInd |
| Member Of Other Entity | false | MemberOfOtherEntityInd |
| Gaming Other Facility | 1.00000 | GamingOtherFacilityPct |
| Individual With Books | EVAN CUCCHIARO | IndividualWithBooksNm |
Persons With Books US Address PersonsWithBooksUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 200 VESEY STREET 28TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10281 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct With3rd Prty For Game Rev | false | CntrctWith3rdPrtyForGameRevInd |
| Gaming Manager Person | EVAN CUCCHIARO SR ACCOUNTANT -JD | GamingManagerPersonNm |
| Gaming Manager Compensation | $0 | GamingManagerCompensationAmt |
| Gaming Manager Services Prov | FILING GAMING APPLICATIONS AND REPORTS | GamingManagerServicesProvTxt |
| Gaming Manager Is Employee | Yes (X) | GamingManagerIsEmployeeInd |
| Charitable Distribution Rqr | false | CharitableDistributionRqrInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE G, PART I, LINE 2 | FormAndLineReferenceDesc |
| Explanation | CHARITABLE ADULT RIDES AND SERVICES (CARS) IS A STATE LICENSED PROFESSIONAL FUNDRAISER THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CONTACT THE COMPANY DIRECTLY THROUGH A TOLL FREE NUMBER TO COORDINATE THE DONATION, FOLLOWING WHICH INSURANCE AUTO AUCTIONS HANDLES ALL REQUIRED IRS 1098C REPORTING. FOR THE PERIOD ENDING 6/30/20, THE CAR PROGRAM RAISED $137,540 WITH TOTAL EXPENSES OF $27,446 WITH THE NET PROCEEDS OF $110,094 PROVIDED DIRECTLY TO JDRF. JDRF PAYS NO ADDITIONAL EXPENSES OR FEES TO INSURANCE AUTO AUCTIONS FOR THIS PROGRAM. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (75 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Valuation Method UsedValuationMethodUsedDesc | Non Cash AssistanceNonCashAssistanceDesc | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|---|
| BENAROYA RESEARCH INST AT VIRGINIA MASON | ||||||||||
| 1201 9TH AVE | SEATTLE | WA | 98101 | 910653422 | 501(C)3 | $1,651,931 | N/A | N/A | ||
| ANN AND ROBERT LURIE CHILDREN'S HOSPITAL | ||||||||||
| 225 EAST CHICAGO AVENUE | CHICAGO | IL | 60611 | 362170833 | 501(C)3 | $175,245 | N/A | N/A | PSYCHOSOCIAL | |
| CAM MED LLC | ||||||||||
| 29 EXETER STREET | WEST NEWTON | MA | 02465 | 464517489 | $198,467 | N/A | N/A | IMMUNE THERAPIES | ||
| UNIVERSITY OF ARIZONA | ||||||||||
| PO Box 245049 | TUCSON | AZ | 850044593 | 113661893 | 501(C)3 | $450,000 | N/A | N/A | ARTIFICIAL PANCREAS | |
| CRITICAL PATH INSTITUTE | ||||||||||
| 1730 EAST RIVER ROAD | TUCSON | AZ | 85718 | 201991334 | 501(C)3 | $164,000 | N/A | N/A | ||
| INDIANA UNIVERSITY | ||||||||||
| 980 INDIANA AVENUE | INDIANAPOLIS | IN | 46202 | 356018940 | 501(C)3 | $938,214 | N/A | N/A | BETA CELL REGENERATION | |
| JOSLIN DIABETES CENTER | ||||||||||
| 1 JOSLIN PL | BOSTON | MA | 02215 | 042203836 | 501(C)3 | $1,621,981 | N/A | N/A | COMPLICATIONS | |
| FREQUENCY THERAPEUTICS | ||||||||||
| 300 TECHNOLOGY SQUARE | WOBURN | MA | 01801 | 472324450 | $87,440 | N/A | N/A | |||
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | ||||||||||
| 77 MASSACHUSETTS AVE | CAMBRIDGE | MA | 02139 | 042103594 | 501(C)3 | $12,049 | N/A | N/A | ||
| INDIANA BIOSCIENCES RES INST | ||||||||||
| 1345 W 16TH STREET | INDIANAPOLIS | IN | 46202 | 462882271 | 501(C)3 | $366,810 | N/A | N/A | BETA CELL REGENERATION | |
| MAYO CLINIC | ||||||||||
| 1216 2ND ST SW | ROCHESTER | MN | 55902 | 411405254 | 501(C)3 | $250,611 | N/A | N/A | IMMUNE THERAPIES | |
| GEORGIA TECH RESEARCH CORP | ||||||||||
| 505 TENTH STREET | ATLANTA | GA | 30332 | 580603146 | 501(C)3 | $326,261 | N/A | N/A | IMMUNE THERAPIES | |
| STANFORD UNIVERSITY | ||||||||||
| 291 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 501(C)3 | $736,781 | N/A | N/A | BETA CELL REGENERATION | |
| NEW YORK STEM CELL FOUNDATION | ||||||||||
| 619 WEST 54TH STREET | NEW YORK | NY | 10019 | 202905531 | 501(C)3 | $449,999 | N/A | N/A | BETA CELL REGENERATION | |
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||
| 3181 SW SAM JACKSON | PORTLAND | OR | 97239 | 237083114 | 501(C)3 | $404,294 | N/A | N/A | PSYCHOSOCIAL | |
| IBM | ||||||||||
| 1 N CASTLE DR | ARMONK | NY | 10504 | 130871925 | $1,125,000 | N/A | N/A | PREVENTION | ||
| PACIFIC DIABETES TECHNOLOGIES | ||||||||||
| 12154 SW GARDEN PLACE | PORTLAND | OR | 97223 | 000000000 | 501(C)3 | $220,689 | N/A | N/A | ||
| UNIVERSITY OF FLORIDA | ||||||||||
| 1600 SW ARCHER ROAD | GAINESVILLE | FL | 32610 | 590974739 | 501(C)3 | $1,413,091 | N/A | N/A | BETA CELL REPLACEMENT | |
| UNIVERSITY OF VIRGINIA | ||||||||||
| 104 MIDMONT LN | CHARLOTTESVILLE | VA | 22902 | 416042488 | 501(C)3 | $67,817 | N/A | N/A | ARTIFICIAL PANCREAS | |
| UNIVERSITY OF MICHIGAN | ||||||||||
| 2003 S STATE STREET | ANN ARBOR | MI | 48109 | 386006309 | 501(C)3 | $2,421,363 | N/A | N/A | BETA CELL REPLACEMENT | |
| LOCKHEED MARTIN | ||||||||||
| 199 BORTON LANDING RD | MOORESTOWN | NJ | 08057 | 521893632 | $87,304 | N/A | N/A | IMMUNE THERAPIES | ||
| UNIVERSITY OF CALIFORNIA | ||||||||||
| 3333 CA ST | SAN FRANCISCO | CA | 94122 | 956006143 | 501(C)3 | $3,650,559 | N/A | N/A | IMMUNOTHERAPIES | |
| UT SOUTHWESTERN MEDICAL CENTER | ||||||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | 756002868 | 501(C)3 | $252,250 | N/A | N/A | ||
| VANDERBILT UNIVERSITY MEDICAL CENTER | ||||||||||
| 1211 MEDICAL CENTER DR | NASHVILLE | TN | 37232 | 620476822 | 501(C)3 | $1,016,666 | N/A | N/A | BETA CELL REGENERATION | |
| LOUISIANA STATE UNIV HEALTH SCIENCE | ||||||||||
| 433 BOLIVAR STREET | NEW ORLEANS | LA | 70112 | 270158443 | 501(C)3 | $125,000 | N/A | N/A | IMMUNE THERAPIES | |
| JAEB CENTER FOR HEALTH RESEARCH FND | ||||||||||
| 15310 Amberly Drive | TAMPA | FL | 33647 | 593187624 | 501(C)3 | $1,907,184 | N/A | N/A | TRANSPORTFOLIO | |
| VIACYTE INC | ||||||||||
| 3550 GENERAL ATOMICS | SAN DIEGO | CA | 92121 | 330884172 | $650,000 | N/A | N/A | BETA CELL REGENERATION | ||
| COLUMBIA UNIVERSITY | ||||||||||
| 535 W 116TH ST | NEW YORK | NY | 10027 | 135598093 | 501(C)3 | $62,640 | N/A | N/A | IMMUNOTHERAPIES | |
| YALE UNIVERSITY | ||||||||||
| PO BOX 209010 | NEW HAVEN | CT | 06520 | 060646973 | 501(C)3 | $866,764 | N/A | N/A | PREVENTION | |
| SFC FLUIDICS INC | ||||||||||
| 534 WEST RES CENTER | FAYETTEVILLE | AR | 72701 | 113682226 | $872,538 | N/A | N/A | ARTIFICIAL PANCREAS | ||
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | ||||||||||
| 1720 2ND AVS S | BIRMINGHAM | AL | 35294 | 636001138 | 501(C)3 | $372,551 | N/A | N/A | ||
| NORTHWESTERN UNIVERSITY | ||||||||||
| 633 CLARK STREET | EVANSTON | IL | 60208 | 231352685 | 501(C)3 | $66,900 | N/A | N/A | IMMUNOTHERAPIES | |
| ICAHN SCHOOL OF MEDICINE MOUNT SINAI | ||||||||||
| 1 GUSTAVE L LEVY PLACE | NEW YORK | NY | 10029 | 136171197 | 501(C)3 | $867,090 | N/A | N/A | ARTIFICIAL PANCREAS | |
| STATE UNIVERSITY OF NY AT BUFFALO | ||||||||||
| 12 CAPEN HALL | BUFFALO | NY | 14260 | 141368361 | 501(C)3 | $667,124 | N/A | N/A | ||
| UNIVERSITY OF MINNESOTA | ||||||||||
| 200 OAK ST SE | MINNEAPOLIS | MN | 55455 | 416007513 | 501(C)3 | $2,063,899 | N/A | N/A | ARTIFICIAL PANCREAS | |
| UNIVERSITY OF WASHINGTON | ||||||||||
| 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195 | 911486484 | 501(C)3 | $250,000 | N/A | N/A | ||
| THE MEDICAL COLLEGE OF WISCONSIN | ||||||||||
| 8701 W WATERTOWN | MILWAUKEE | WI | 53226 | 611730890 | 501(C)3 | $584,260 | N/A | N/A | IMMUNE THERAPIES | |
| TIDEPOOL | ||||||||||
| 555 BRYANT | ST PALO ALTO | CA | 94301 | 462302287 | $650,000 | N/A | N/A | ARTIFICIAL PANCREAS | ||
| UNIVERSITY OF UTAH | ||||||||||
| 201 PRESIDENTS CR | SALT LAKE CITY | UT | 84112 | 876000525 | 501(C)3 | $765,065 | N/A | N/A | IMMUNOTHERAPIES | |
| PROTOMER TECHNOLOGIES | ||||||||||
| 530 SOUTH LAKE AVE | PASADENA | CA | 91101 | 474206994 | $356,314 | N/A | N/A | IMMUNE THERAPIES | ||
| UNIVERSITY OF COLORADO | ||||||||||
| 1800 GRANT STREET | DENVER | CO | 80203 | 846049811 | 501(C)3 | $3,623,140 | N/A | N/A | PREVENTION | |
| UNIVERSITY OF ILLINOIS | ||||||||||
| 1200 HARRISON | CHICAGO | IL | 60612 | 376006007 | 501(C)3 | $771,252 | N/A | N/A | ARTIFICIAL PANCREAS | |
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | ||||||||||
| 1 COLLEGE HALL | PHILADELPHIA | PA | 19104 | 231352685 | 501(C)3 | $42,621 | N/A | N/A | IMMUNE THERAPIES | |
| UNIVERSITY OF TEXAS HEALTH SCIENCE | ||||||||||
| 7703 FLOYD CURL DRIVE | SAN ANTONIO | TX | 78229 | 741586031 | 501(C)3 | $480,505 | N/A | N/A | METABOLIC CONTROL | |
| WASHINGTON UNIVERSITY | ||||||||||
| One Brookings Drive | St Louis | MO | 63130 | 430653611 | 501(C)3 | $542,203 | N/A | N/A | BETA CELL REPLACEMENT | |
| VTV THERAPEUTICS LLC | ||||||||||
| 4170 MENDENHALL OAKS | HIGH POINT | NC | 27265 | 113682226 | $600,000 | N/A | N/A | IMMUNE THERAPIES | ||
| BOSTON CHILDREN'S HOSPITAL | ||||||||||
| 300 LONGWOOD AVENUE | BOSTON | MA | 02115 | 043266103 | 501(C)3 | $1,859,050 | N/A | N/A | BETA CELL REPLACEMENT | |
| HARVARD COLLEGE | ||||||||||
| 677 HUNTINGTON AVE | BOSTON | MA | 02115 | 042103580 | 501(C)3 | $4,312,693 | N/A | N/A | BETA CELL REPLACEMENT | |
| IVIVA MEDICAL INC | ||||||||||
| 100 CUMMINGS CENTER | BEVERLY | MA | 01915 | 000000000 | $45,000 | N/A | N/A | BETA CELL REPLACEMENT | SUITE 451C | |
| JOHNS HOPKINS UNIVERSITY | ||||||||||
| 3400 N CHARLES STREET | BALTIMORE | MD | 21218 | 520595110 | 501(C)3 | $13,638 | N/A | N/A | IMMUNOTHERAPIES | |
| PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY | ||||||||||
| 1 LETTERMAN DR STE D3500 | SAN FRANCISCO | CA | 94129 | 473355381 | 501(C)3 | $1,106,749 | N/A | N/A | ||
| PHYSIOLOGIC DEVICES INC | ||||||||||
| 2232 OLD STAGECOACH TRAIL | ALPINE | CA | 91901 | 000000000 | $962,000 | N/A | N/A | |||
| SINCLAIR RESEARCH CENTER LLC | ||||||||||
| 562 STATE ROAD DD | AUXVASSE | MO | 65231 | 000000000 | $122,027 | N/A | N/A | |||
| STOWERS INSTITUTE FOR MEDICAL RESEARCH | ||||||||||
| 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 202993509 | 501(C)3 | $147,893 | N/A | N/A | ||
| THE OHIO STATE UNIVERSITY | ||||||||||
| 281 W LANE AVE | COLUMBUS | OH | 43210 | 261416129 | 501(C)3 | $185,000 | N/A | N/A | ||
| THE SCRIPPS RESEARCH INSTITUTE | ||||||||||
| 10550 N TORREY PINES RD | LA JOLLA | CA | 92037 | 330435954 | 501(C)3 | $441,100 | N/A | N/A | BETA CELL REGENERATION | |
| THE UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER | ||||||||||
| 1000 STANTON L YOUNG BLVD | OKLAHOMA CITY | OK | 73104 | 731563627 | 501(C)3 | $250,000 | N/A | N/A | COMPLICATIONS | |
| UNIVERSITY OF MIAMI | ||||||||||
| 1320 S DIXIE HWY STE 760 | CORAL GABLES | FL | 33146 | 590624458 | 501(C)3 | $467,579 | N/A | N/A | BETA CELL REPLACEMENT | |
| UNIVERSITY OF NEBRASKA BOARD OF REGENTS | ||||||||||
| 3835 HOLDREGE | LINCOLN | NE | 68583 | 470049123 | 501(C)3 | $349,998 | N/A | N/A | PREVENTION | VARNER HALL |
| VANDERBILT UNIVERSITY | ||||||||||
| 2301 VANDERBILT PLACE | NASHVILLE | TN | 37240 | 620476822 | 501(C)3 | $262,640 | N/A | N/A | METABOLIC CONTROL | |
| WAVE 80 BIOSCIENCES | ||||||||||
| 2325 THIRD ST | SAN FRANCISCO | CA | 94107 | 000000000 | $39,992 | N/A | N/A | PREVENTION | SUITE 215 | |
| ADVANCED REGENERATIVE MANUFACTURING INSTITUTE | ||||||||||
| 400 COMMERCIAL STREET | MANCHESTER | NH | 03101 | 813327581 | 501(C)(3) | $1,279,011 | N/A | N/A | BETA CELL REPLACEMENT | |
| ALBERT EINSTEIN COLLEGE OF MEDICINE INC | ||||||||||
| 1300 MORRIS PARK AVENUE | BRONX | NY | 10461 | 472209056 | $110,000 | N/A | N/A | IMMUNOTHERAPIES | BELFER 312 | |
| ARIZONA STATE UNIVERSITY | ||||||||||
| PO Box 873503 | TEMPE | AZ | 85281 | 860196696 | 501(C)(3) | $110,000 | N/A | N/A | BETA CELL REPLACEMENT | |
| BALLAD RESEARCH INSTITUTE | ||||||||||
| 10865 ROAD TO THE CURE | SAN DIEGO | CA | 921211155 | 611771290 | 501(C)(3) | $250,000 | N/A | N/A | IMMUNOTHERAPIES | |
| BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE | ||||||||||
| 1500 E DUARTE RD | DUARTE | CA | 91010 | 953432210 | 501(C)(3) | $402,643 | N/A | N/A | BETA CELL REGENERATION | |
| CHILDREN'S HOSPITAL OF PHILADELPHIA | ||||||||||
| 3401 CIVIC CTR BLVD | PHILADELPHIA | PA | 19104 | 232237932 | 501(C)(3) | $149,999 | N/A | N/A | PREVENTION | |
| COLORADO SCHOOL OF MINES | ||||||||||
| 1500 ILLINOIS ST | GOLDEN | CO | 80401 | 846000551 | 501(C)(3) | $109,984 | N/A | N/A | BETA CELL REGENERATION | |
| IQVIA INC | ||||||||||
| 4820 EMPEROR BLVD | DURHAM | NC | 27703 | 271341991 | $198,500 | N/A | N/A | PREVENTION | ||
| O2M TECHNOLOGIES LLC | ||||||||||
| HTI ENTERPRISEWORKS | CHICAGO | IL | 60612 | 000000000 | $512,762 | N/A | N/A | BETA CELL REPLACEMENT | 2242 W HARRISON ST STE 201-18 | |
| SAB BIOTHERAPEUTICS INC | ||||||||||
| 2301 E 60TH ST N | SIOUX FALLS | SD | 57104 | 000000000 | $100,000 | N/A | N/A | IMMUNOTHERAPIES | ||
| SAINT LOUIS UNIVERSITY | ||||||||||
| 1 N GRAND BLVD | SAINT LOUIS | MO | 63103 | 430654872 | 501(C)(3) | $110,000 | N/A | N/A | METABOLIC CONTROL | |
| T1D EXCHANGE INC | ||||||||||
| 11 AVENUE DE LAFAYETTE | BOSTON | MA | 02111 | 475074602 | 501(C)(3) | $25,000 | N/A | N/A | TRANSPORTFOLIO | 5TH FL |
| UNIVERSITY OF NOTRE DAME | ||||||||||
| 182 FITZPATRICK HALL | NOTRE DAME | IN | 46556 | 350868188 | 501(C)(3) | $150,000 | N/A | N/A | METABOLIC CONTROL | |
| UNIVERSITY OF PITTSBURGH | ||||||||||
| 4200 FIFTH AVE | PITTSBURGH | PA | 15260 | 250965591 | 501(C)(3) | $475,610 | N/A | N/A | PREVENTION | CENTRAL PLANT NO 3 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 58 | Total501c3OrgCnt |
| Total Other Org | 17 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | GRANT MONITORING PROCEDURES | FormAndLineReferenceDesc |
| Explanation | SCH-I PART I LINE 2 RESEARCH GRANTS ARE AWARDED BY JDRF INTERNATIONAL WITH THE SUPPORT OF JDRFIs RESEARCH COMMITTEE COMPRISED OF "JDRF INTERNATIONAL BOARD MEMBERS AND OTHER VOLUNTEERSTHE JDRF INTERNATIONAL BOARD OF DIRECTORS FOLLOWING THE RECOMMENDATIONS OF AN IN-HOUSE TEAM OF PROFESSIONAL SCIENTIFIC STAFF AND WITH INPUT FROM EXTERNAL SCIENTIFIC REVIEWERS. THE REVIEW PROCESS INCLUDES THE FOLLOWING CRITERIA: (1) THE SCIENTIFIC MERIT OF THE PROPOSED RESEARCH OUTLINED IN A GRANT APPLICATION AND (2) THE RELATIONSHIP OF THE PROPOSED RESEARCH TO JDRF'S GOAL TO IMPROVE LIVES TODAY AND TOMORROW BY ACCELERATING LIFE-CHANGING BREAKTHROUGHS TO CURE, PREVENT AND TREAT T1D AND ITS COMPLICATIONS. THE SCIENTIFIC RESEARCH TEAM AND GRANT ADMINISTRATION STAFF MAINTAIN CLOSE CONTACT WITH GRANTEES, PROVIDING ADVICE AND EVALUATION, REVIEWING PROGRESS REPORTS, REVIEWING RESEARCH EXPENDITURES VERSUS AGREED BUDGETS, AND HELPING DISSEMINATE RESEARCH RESULTS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Housing Allowance Or Residence | Yes (X) | HousingAllowanceOrResidenceInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | false | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (12 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AARON KOWALSKI | ||||||||||||||
| PRESIDENT AND CEO | $460,000 | $0 | $140,000 | $0 | $54,519 | $0 | $12,375 | $0 | $33,917 | $0 | $700,811 | $0 | $0 | $0 |
| SANDRA HIJIKATA THRU 0420 | ||||||||||||||
| CHIEF DEV OFFICER & ASST. SECY | $378,750 | $0 | $71,800 | $0 | $0 | $12,375 | $0 | $12,569 | $0 | $475,494 | $0 | $0 | $0 | |
| JILL CLARK | ||||||||||||||
| SVP, VOLUNTEER ENGAGEMENT | $285,000 | $0 | $74,900 | $0 | $0 | $0 | $12,375 | $0 | $7,213 | $0 | $379,488 | $0 | $0 | $0 |
| ALISA NORRIS | ||||||||||||||
| CHIEF MARKETING OFFICER | $360,000 | $0 | $15,000 | $0 | $0 | $12,375 | $0 | $34,613 | $0 | $421,988 | $0 | $0 | $0 | |
| SUSAN YUN THRU 0520 | ||||||||||||||
| CHIEF PEOPLE OFFICER/ASST. SEC | $298,333 | $0 | $75,100 | $0 | $0 | $0 | $12,375 | $0 | $2,598 | $0 | $388,406 | $0 | $0 | $0 |
| CYNTHIA RICE | ||||||||||||||
| CHIEF MISSION OFFICER | $298,034 | $0 | $72,800 | $0 | $0 | $12,375 | $0 | $18,777 | $0 | $401,986 | $0 | $0 | $0 | |
| JOANNE MARTZ | ||||||||||||||
| CFO/TREASURER | $353,333 | $0 | $62,800 | $0 | $0 | $9,987 | $0 | $24,929 | $0 | $451,049 | $0 | $0 | $0 | |
| HELEN ELIAS | ||||||||||||||
| MANAGING DIR. JDRF T1D FUND | $260,350 | $0 | $153,800 | $0 | $36,348 | $0 | $0 | $25,833 | $0 | $476,331 | $0 | $0 | $0 | |
| SYDNEY YOVIC | ||||||||||||||
| CHIEF OF STAFF/ASST. TREASURER | $165,985 | $0 | $19,100 | $0 | $0 | $8,140 | $0 | $24,844 | $0 | $218,069 | $0 | $0 | $0 | |
| DEREK RAPP THRU 0419 | ||||||||||||||
| PRESIDENT AND CEO | $215,158 | $0 | $270,828 | $0 | $384,385 | $0 | $0 | $0 | $11,538 | $0 | $881,909 | $0 | $0 | $0 |
| SRINIVAS MISHRA | ||||||||||||||
| CHIEF DATA AND TECHNOLOGY | $312,667 | $0 | $50,400 | $0 | $0 | $24,929 | $0 | $9,132 | $0 | $397,128 | $0 | $0 | $0 | |
| SANJOY DUTTA | ||||||||||||||
| VP, RESEARCH | $256,771 | $0 | $29,400 | $0 | $0 | $12,338 | $0 | $3,817 | $0 | $302,326 | $0 | $0 | $0 | |
Supplemental Information Detail SupplementalInformationDetail (3 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| HOUSING ALLOWANCE | SCHEDULE J PART I, LINE 1A Pres & CEO Aaron Kowalski and Managing Director of the JDRF T1D Fund Helen Elias both received a housing allowance as per the terms of their employment agreements. The totals for both are as follows: Aaron Kowalski - $54,519 Helen Elias - $36,348 For the 2019 calendar year, the housing allowance provided to Derek Rapp was $25,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J, Part II, Col. (B) (III). |
| NON-FIXED PAYMENTS | FORM 990, SCHEDULE J, PART I, LINE 7 JDRF AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEES PERFORMANCE. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2, PART II, COL. (B) (II). |
| SEVERANCE PAYMENTS | SCHEDULE J, PART I, LINE 4A DEREK RAPP RECEIVED A SEVERANCE PAYMENT OF $359,385 WHICH IS REPORTED ON SCHEDULE J, PART II, COL. (B)(III) OTHER REPORTABLE COMPENSATION. |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp |
Cars And Other Vehicles CarsAndOtherVehiclesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 5 | ContributionCnt |
| Noncash Contributions Rpt F990 | $223,503 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | APPRAISAL | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 328 | ContributionCnt |
| Noncash Contributions Rpt F990 | $5,097,576 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | NET PROCEEDS OF SALE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | MISC AUCTION ITEMS DONATED | Desc |
| Contribution | 14900 | ContributionCnt |
| Noncash Contributions Rpt F990 | $6,839,325 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FAIR MARKET VALUE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | Yes (true) | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| THIRD PARTY ASSISTANCE | LINE 32B CHARITABLE ADULT RIDES AND SERVICES (CARS) IS A THIRD PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CALL A TOLL FREE NUMBER AND THEY ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, CARS HANDLES ALL IRS 1098-C REPORTING. CARS IS A LICENSED PROFESSIONAL FUNDRAISER AND IS LICENSED IN THE STATES THAT REQUIRE IT TO REGISTER. FOR THE PERIOD ENDING 6/30/20, CARS RAISED $137,740 WITH TOTAL EXPENSES OF $27,446. A NET CHECK IS PAID DIRECTLY TO JDRF. JDRF DOES NOT PAY CARS ANY EXPENSES OR FEES DIRECTLY. TOTAL NET REVENUE FOR FY-20 WAS $110,094. |
| NONCASH CONTRIBUTIONS | FORM 990, SCHEDULE M, PAGE 1 TYPES OF PROPERTY AND THE AMOUNTS LISTED IN PART I LINES 6, 9, and 25 ARE THE ACTUAL AMOUNT THAT DONORS HAVE DONATED FOR VEHICLES, SECURITIES, AND MISC ITEMS THAT ARE SOLD AT VARIOUS AUCTIONS & RAFFLES. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PUBLIC DOCUMENTS | FORM 990, PAGE 6, PART VI, SECTION C, LINE 19 The organization makes its governing documents, conflict of interest policy and financial statements available to the public on its website: www.JDRF.org. The public may access copies of JDRF's W-9, annual reports, 990 tax returns, 501(c)(3) IRS letter, and audited financials, at the following link: www.jdrf.org/about/financials |
| EXECUTIVE COMPENSATION POLICY | PART VI, SECTION B, LINES 15a & 15b JDRF's Board of Directors charges a Talent and Compensation Committee to develop and recommend a compensation philosophy that applies to all employees of JDRF, including recommendations regarding the compensation and benefits of JDRF senior management for approval by the Board of Directors. The Committee works in collaboration with the President and CEO and the Chief People Officer and other senior staff personnel in the JDRF Human Resources Department to ensure that 1) the Foundation's talent strategy supports and is aligned with its overall organization strategies; 2) JDRF is in compliance with IRS guidelines for determining reasonableness in pay practices; and 3) overall compensation for JDRF's key executives is competitive and aligned with pay philosophy. To attract and retain top scientific and executive talent to advance its mission, the organization pays competitive and appropriate salaries as determined by analysis of reliable data and input from independent third-party consultants. The review of JDRF executive compensation and benefits under the procedures noted above is completed annually by an independent Compensation Committee, and the basis for their determination is documented contemporaneously in the minutes of the Committee's meetings, including most recently on June 30, 2020. |
| FORM 990 REVIEW PROCESS | SECTION B, PART VI, QUESTION 11B JDRF has a rigorous standard approach to reviewing its 990. The Organization's Senior Accountant works with its outside tax preparers to prepare the return and all supporting schedules. The draft return is reviewed by a number of individuals, including JDRF's Chief Financial Officer and AVP, FINANCE, the Chief Executive Officer, other executives, its external senior tax advisor and others as necessary to ensure accuracy. Any questions and changes with respect to the draft return are addressed. Following this process, the return is reviewed by JDRF's Audit Committee of the Board of Directors with its outside tax advisors. Once approved, the return is distributed to all members of JDRF's Board of Directors for review and comment before it is filed with the Internal Revenue Service. |
| PART III: STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS | LINE 4A ($68,847,301) RESEARCH GRANTS JDRF has played a significant role in nearly every T1D therapeutic advance made in the last 50 years. Our funding supports more than 500 active T1D research grants in the United States and 21 other countries around the world including more than 150 grants in 2020 alone, plus 75 clinical trials. We leverage partnerships with academia, industry and clinicians to accelerate the most promising research opportunities. Our highest priority is developing cures for T1D and improving lives of those living with the disease today, including research in glucose control and prevention of T1D complications. The full impact of JDRF's research investment extends well beyond direct funding. Through advocacy and influence, JDRF drives funding from other sources into the T1D research and has helped secure passage of the Special Diabetes Program, putting more than $3 billion in federal funding toward T1D research over the last two decades. In addition, JDRF founded the JDRF T1D Fund (www.t1dfund.org). The wholly owned subsidiary of JDRF, the Fund is a venture philanthropy fund accelerating life-changing solutions to treat, prevent and cure T1D through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, pharma and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines to help people living with T1D or at risk of developing the disease. The T1D Fund invests in opportunities that drive our mission, with an exclusive focus on the best commercial opportunities. All funds go directly to support companies developing approaches to treat, prevent and cure T1D. In accordance with GAAP, $50MM of the T1D Fund's total investments as of June 30, 2020 are reflected in the Balance Sheet (Part X) and not included within the organization's research-related mission expense. The foundation's diversified research portfolio includes a focus on Curing T1D and Improving Lives. Curing T1D We face two key challenges in Curing T1D. We must prevent, stop or reverse: the loss of insulin-producing beta cells, and the immune systems attack on beta cells. JDRF is accelerating our work in Curing T1D by focusing on the two areas that have advanced dramatically over the last years: Beta Cell Therapies and Immune Therapies. Beta Cell Therapies: focus on replacing insulin-producing beta cells from outside sources and on internally regenerating and protecting existing beta cells. Through donor-funded research, we now know that when someone has T1D, their own body turns on itself, attacking and destroying the beta cells that create insulin. Understanding the role of beta cells -- was a breakthrough. If we can save beta cells, we can help cure T1D. Immune Therapies: focus on ways to keep the immune system from attacking and destroying beta cells, and to prevent the onset and advancement of T1D. Research has shown that immune therapies can interact with a persons immune system, training it to combat internal battles like cancer or autoimmune diseases like rheumatoid arthritis and T1D. While T1D remains one of the only major autoimmune diseases without an effective drug therapy, we know we are getting close. Improving Lives T1D brings with it daily struggles and stress that that make the challenges of living a healthy and long life with T1D very real. JDRF fights every day to advance research and technology that can reduce the burden of living with T1D and keep people as healthy as possible until we find cures. Specifically, we are striving to improve lives by driving research and work in Glucose Control Therapies and Complications Therapies which includes psychosocial well-being. Glucose Control Therapies: focus on helping those with T1D manage glucose levels and overall metabolic balance, including improved artificial pancreas technology, developing next-generation insulins and developing new drugs that control glucose in novel ways. We know that less than 30% of people with T1D in the U.S. consistently maintain target blood-glucose control levels meaning that 70% are at risk of serious health issues. Aiming to ensure our community is healthy when cures are found, we will continue our focus on bringing new innovation to this area, including improved artificial pancreas technology, next-generation insulins and new drugs that control glucose in novel ways. Complications Therapies: focus on accelerating therapies to prevent and treat kidney and eye disease and improving psychosocial well-being. We know that more than 90% of people with T1D develop eye disease within 20 years of diagnosis and that 1 in 4 develop kidney disease. We also know that prevalence of suicide is higher among young adults with T1D. Our focus on complications will be on accelerating therapies that prevent and treat kidney and eye disease. We also are expanding our support of psychosocial wellbeing. We have been supporting research of psychosocial wellbeing for several years. Now we are increasing our support as early research has shown that the burden of living with T1D takes a toll well beyond physical complications. Research also has shown us that young adults and teens with T1D are often impacted the most, with a significantly higher suicide rate. This is alarming and is our call to step up this work to help make a positive difference. LINE 4B ($16,997,889) RESEARCH SUPPORT JDRF's in-house team of skilled and credentialed scientific, policy and government relations professionals play critical roles in leading and supporting the research strategy and distribution of research funds from JDRF - and our partner organizations toward creating a world without T1D. Our professionals identify, evaluate and influence groundbreaking research for funding and work with other foundations, governments and industry to accelerate the mission we all share. JDRF professionals work with regulatory and policy officials to ensure research can proceed without delay and that advances are well understood by healthcare decision makers. As part of these efforts, JDRF organizes and funds scientific meetings, symposia, and conferences to review research proposals, ensure that JDRF's research strategy is aligned with the needs of the T1D community, and allow JDRF to provide scientific updates on the research it manages. This effort ensures that all the research is continually shared and built upon by T1D researchers around the globe. The Strategic Advisory Panel is composed of five established T1D experts in various aspects of the field, including pediatric endocrinology, prevention and treatment of T1D, immunotherapies, regulatory and drug development. The SAP contributes to JDRF scientists strategic planning around research funding goals and priorities. JDRF's work to bring together the best minds in the field enhances JDRF's ability to forecast future scientific direction, judge the potential effectiveness of new pathways, and identify gaps where JDRF funding can make the most impact. LINE 4C ($50,681,132) PUBLIC EDUCATION JDRF is uniquely qualified to provide public education about diabetes and its complications. JDRF's efforts impact not only the millions of people living with T1D, their families and the general public, but also those at risk for developing the disease. T1D strikes both children and adults suddenly, and the critical adjustment period following a diagnosis can be overwhelming. That's why we support families navigating this challenging time. JDRF also educates people about the warning signs of T1D, aimed at ensuring timely diagnoses and reducing the potential catastrophic consequences of undiagnosed T1D. JDRF also provides information and updates about current research directions and progress and about human clinical trials that are seeking participants (including through JDRF's Clinical Trials Connection matching tool: www.jdrf.org/research/clinical-trials). Through all of our national U.S. chapters; five international affiliates in Australia, Canada, Israel, the Netherlands and United Kingdom; the 30,000 members of our social network, TypeOneNation; and more than one million supports, JDRF fights to meet T1D community's diverse needs, connecting people with local support, expert resources, and the global effort to create a world without T1D. |
| CONFLICT OF INTEREST POLICY | FORM 990- PART VI-SECT B, LINE 12C All officers, directors, key employees, board and committee members (both chapters and international boards) are required to sign a conflict of interest policy annually and disclose any conflicts. The Office of the President and CEO manages this process, and JDRF's internal audit department annually audits to ensure compliance. If any conflict does arise, the board members with the conflicts will recuse themselves from the meeting and/or vote. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF T1D FUND LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | C/O JDRF - 200 VESEY STREET 28TH FL | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10281 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 274967989 | EIN |
| Primary Activities | FUNDR/INVEST | PrimaryActivitiesTxt |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Total Income | $23,329,961 | TotalIncomeAmt |
| End Of Year Assets | $98,752,344 | EndOfYearAssetsAmt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF | BusinessNameLine1Txt |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CHARITABLE REMAINDER TRUST (5) | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | ANNUITY | PrimaryActivitiesTxt |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Controlled Organization | Yes (true) | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE R, PART I, LINE (1B) | FormAndLineReferenceDesc |
| Explanation | THE PRIMARY ACTIVITY FOR THE JDRF T1D FUND IS FUNDRAISING AND INVESTING IN TYPE ONE DIABETES RESEARCH. PLEASE SEE DETAILED DESCRIPTION ON SCHEDULE O, PART III, LINE 4A, STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS FOR RESEARCH GRANTS. | ExplanationTxt |